ÂÜÀòÂÒÂ×

Jackie Hunter, PhD, DSc, CBE, FBPharmacolS, FMedSci, FZSL, is a prominent figure in the pharmaceutical and biotechnology sectors, currently serving as Chair at Brainomix until March 2025 and as CEO of OI Pharma Partners Ltd. since April 2010, where innovation in AI and machine learning is prioritized. Previous roles include Chief Executive at BBSRC from October 2013 to February 2016, and CEO of Benevolent Bio Ltd and Board Director at BenevolentAI from March 2016 to June 2020. Jackie Hunter has held various senior positions at GlaxoSmithKline, including SVP Science Environment Development, VP Biology, and SVP & Head Neurology and GI CEDD. Additional experience includes serving as a Non-executive Director at Proximagen and being a Member of the Board of Advisors at Digital Science since March 2024. Educational background includes a BSc and PhD in Psychology from Royal Holloway, University of London.